Search Orphan Drug Designations and Approvals
-
Generic Name: | Fampridine |
---|---|
Date Designated: | 06/02/1997 |
Orphan Designation: | Treatment of chronic, incomplete spinal cord injury. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Acorda Therapeutics, Inc. 15 Skyline Dr. Hawthorne, New York 10532 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-